Drugs / Sodium selenate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02112643 Comparator | Oct 2015 → Nov 2016 | disease of orbital part of eye adnexa | Columbia University | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium selenate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02112643 ↗ |
| Known as | NSC-378348 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2097002 ↗ |
| Modality | Small molecule | — CHEMBL2097002 ↗ |
| Route | Oral | “will be orally administered” NCT02112643 ↗ |